A Report of the American Society of Nuclear Cardiology Task Force on Women and Heart Disease (Writing Group on Perfusion Imaging in Women)

Journal of Nuclear Cardiology

Volumn 10, Issue 1, 2003, Pages 95-101

  Mieres, Jennifer H ^a   Shaw, Leslee J ^a   Hendel, Robert C ^a   Miller, D Douglas ^a   Bonow, Robert O ^a   Berman, Daniel S ^a   Heller, Gary V ^a  

^a American Society of Nuclear Cardiol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE;

ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EVIDENCE BASED MEDICINE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART MUSCLE PERFUSION; HUMAN; MEDICAL SOCIETY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; TREATMENT INDICATION;

EID: 0037226122     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.130362     Document Type: Review

References (58)

1. American Heart Association. Heart and stroke facts: 2002 statistical supplement. Dallas: American Heart Association; 2002.
2. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92.
3. Shaw LJ, Miller DD, Romeis JC, et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-66.
4. Tobin JN, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med 1987;107:19-25.
5. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med 1996;334:1311-5.
6. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med 1991;325:226-30.
7. Kilaru PK, Kelly RF, Calvin JE, Parillo JE. Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart Association guidelines. J Am Coll Cardiol 2000;35:974-9.
8. Mark DB, Shaw LK, Delong ER, et al. Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med 1994;330:1101-6.
9. Hochleitner M. Coronary heart disease: sexual bias in referral for coronary angiogram. How does it work in a state-run health system? J Womens Health Gend Based Med 2000;9:29-34.
10. Wong CC, Froelicher ES, Bacchetti P, et al. Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiography. Circulation 1997;96:II51-7.
11. Mosca L, Grundy SM, Judelson D, et al. AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. J Am Coll Cardiol 1999;33:1751-5.
12. Hlatky MA, Pryor DB, Harrel FE Jr, et al. Factors affecting sensitivity and specificity of exercise electrocardiography: multivariable analysis. Am J Med 1984;77:64-71.
13. Heller GV, Fossati AT. Chapter 18. Detection of coronary artery disease in women. In: Zaret B, Beller G, editors. Nuclear cardiology: state of the art and future directions. 2nd ed. St. Louis; Mosby; 1999. p. 298-311.
14. Kwok YS, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.
15. Morise AP, Dalal JN, Duval RD. Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women. Am J Med 1993;94:491-6.
16. Kawano H, Motoyama T, Ohgushi K, et al. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 2001;135:977-81.
17. Schulman SP, Thiemann DR, Ouyang P, et al. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. J Am Coll Cardiol 2002;39:231-7.
18. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing: executive summary. J Am Coll Cardiol 1997;96:345-54.
19. Okin PM, Kligfield PM. Gender-specific criteria and performance of the exercise electrocardiogram. Circulation 1995;92:1209-16.
20. Alexander KP, Shaw LJ, Delong ER, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998;32:1657-64.
21. Nesto RW, Phillips RT, Kett KG, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:170-5.
22. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
23. Hachamovitch R, Berman DS, Kiat H, et al. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms. An evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823-9.
24. Depuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995;36:952-5.
25. Iskandrian AE, Jaekyeong H, Nallamothu N. Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol 1997;4:329-35.
26. Marwick T, Shaw L, Lauer M, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease: Economics of Noninvasive Diagnosis (END) study group. Am J Med 1999;106:172-8.
27. Hendel R, Chen M, L'Italien G, et al. Sex differences in perioperative and long term cardiac event-free survival in vascular surgery patients. Circulation 1995;91:1044-51.
28. Santana-Boado C, Candell-Riera J, Castell-Conesa, et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998;39:751-5.
29. Hachamovitch R, Berman D, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion single-photon emission computed tomography SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996;28:34-44.
30. Friedman TD, Greene AC, Iskandrian AS, et al. Exercise thallium-2091 myocardial perfusion scintigraphy in women: correlation with coronary arteriography. Am J Cardiol 1982;49:1632-7.
31. Goodgold HM, Rehder JG, Samuels LD, Chaitman BR. Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women: characterization of breast attenuation artifacts. Radiology 1987;165:361-6.
32. Amanullah AM, Berman DS, Hachamovitch R, et al. Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 1997;80:132-7.
33. Kong BA, Shaw L, Miller DD, Chaitman BR. Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Am J Cardiol 1992;70:168-73.
34. Amanullah A, Berman D, Erel J, et al. Incremental diagnostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998;82:725-30.
35. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber. J Am Coll Cardiol 1996;67:69-77.
36. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
37. Travin MI, Katz MS, Moulton AW, et al. Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenosis and multivessel disease in women versus men. J Nucl Cardiol 2000;7:213-20.
38. Geleijnse M, Elhendy A, Domburg R, et al. Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 1996;77:1057-61.
39. Amanullah AM, Kiat H, Hachamovitch R, et al. Impact of myocardial perfusion single-photon emission computed tomography on referral to catheterization of the very elderly. Is there evidence of gender-related referral bias? J Am Coll Cardiol 1996;28:680-6.
40. Pancholy S, Fattah A, Kamal A, et al. Independent and incremental prognostic value of exercise thallium single-photon emission tomographic imaging in women. J Nucl Cardiol 1995;2:110-6.
41. Travin M, Duca M, Kline G, et al. Relation of gender to physician use of test results and prognostic value of technetium 99m myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997;134:78-82.
42. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140-5.
43. Galassi AR, Azzarelli S, Tomaselli A, et al. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected of known coronary artery disease. Am J Cardiol 2001;88:101-6.
44. Vanzetto G, Ormezzano O, Farget D, et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6 year follow-up. Circulation 1999;100:1521-7.
45. Olmos LI, Dakik H, Gordon R, et al. Long-term prognostic value of exercise echocardiography compared with exercise 201 Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998;98:2679-86.
46. Alkeylani A, Miller DD, Shaw LJ, et al. Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris. Am J Cardiol 1998;81:293-7.
47. Snader CE, Marwick TH, Pashkow FJ, et al. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 1997;30:641-8.
48. Boyne TS, Koplan BA, Parsons WJ, et al. Predicting adverse outcome with exercise SPECT technetium-99m-sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol 1997;79:270-4.
49. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997;96:137-47.
50. Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202-8.
51. Machecourt J, Longere P, Pagret D, et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994;23:1096-106.
52. Kamal AM, Fattah AA, Pancholy S, et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994;1:254-61.
53. Stratman HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
54. Stratman HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994;89:615-22.
55. Groutars RG, Verzijbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual isotope myocardial SPECT. J Nucl Cardiol 2000;7:333-41.
56. Soman P, Parsons A, Lahiri N, Lahiri A. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999;6:252-6.
57. Cacciabaudo JM, Hachamovitch R. Stress myocardial perfusion SPECT in women: is it the cornerstone of the noninvasive evaluation? J Nucl Med 1998;39:758-9.
58. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the executive summary and recommendations. J Am Coll Cardiol 1999;33:2092-197.